MIRM Mirum Pharmaceuticals Inc

$70.97

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Mirum Pharmaceuticals Inc

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California.

Website: https://www.mirumpharma.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1759425
Address
950 TOWER LANE, SUITE 1050, FOSTER CITY, CA, US
Valuation
Market Cap
$1.93B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
8.57
Performance
EPS
$-1.85
Dividend Yield
—
Profit Margin
-26.10%
ROE
-37.10%
Technicals
50D MA
$45.89
200D MA
$42.72
52W High
$54.23
52W Low
$23.14
Fundamentals
Shares Outstanding
49M
Target Price
$63.78
Beta
1.01

MIRM EPS Estimates vs Actual

● Estimated
● Actual

MIRM News & Sentiment

Nov 05, 2025 • Zacks Commentary SOMEWHAT-BULLISH
MIRM's Q3 Earnings & Revenues Beat Estimates, 2025 View Tightened
Mirum posts third-quarter profit and stronger revenues on surging Livmarli demand, while tightening its 2025 sales outlook.
Nov 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Mirum Pharmaceuticals, Inc. ( MIRM ) Surpasses Q3 Earnings and Revenue Estimates
Mirum Pharmaceuticals (MIRM) delivered earnings and revenue surprises of +150.00% and +0.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 29, 2025 • Zacks Commentary NEUTRAL
Techne ( TECH ) Reports Next Week: What to Know Ahead of the Release
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 14, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings?
MIRM's Livmarli remains its dominant growth engine and is expected to have boosted its top line in the third quarter.
Oct 07, 2025 • Zacks Commentary BULLISH
Is First Trust Small Cap Growth AlphaDEX ETF ( FYC ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Sep 26, 2025 • Zacks Commentary BULLISH
Should First Trust Small Cap Growth AlphaDEX ETF ( FYC ) Be on Your Investing Radar?
Style Box ETF report for ...
Sentiment Snapshot

Average Sentiment Score:

0.088
50 articles with scored sentiment

Overall Sentiment:

Neutral

MIRM Reported Earnings

Aug 06, 2025
Jun 30, 2025 (Pre market)
0.21 Surprise
  • Reported EPS: $-0.12
  • Estimate: $-0.33
  • Whisper: —
  • Surprise %: 63.6%
May 07, 2025
Mar 31, 2025 (Pre market)
0.18 Surprise
  • Reported EPS: $-0.30
  • Estimate: $-0.48
  • Whisper: —
  • Surprise %: 37.5%
Feb 26, 2025
Dec 31, 2024 (Pre market)
-0.24 Surprise
  • Reported EPS: $-0.49
  • Estimate: $-0.25
  • Whisper: —
  • Surprise %: -98.7%
Nov 12, 2024
Sep 30, 2024 (Post market)
0.15 Surprise
  • Reported EPS: $-0.30
  • Estimate: $-0.45
  • Whisper: —
  • Surprise %: 33.8%
Aug 07, 2024
Jun 30, 2024 (Post market)
-0.05 Surprise
  • Reported EPS: $-0.52
  • Estimate: $-0.47
  • Whisper: —
  • Surprise %: -10.6%
May 08, 2024
Mar 31, 2024 (Post market)
-0.06 Surprise
  • Reported EPS: $-0.54
  • Estimate: $-0.48
  • Whisper: —
  • Surprise %: -12.5%
Feb 28, 2024
Dec 31, 2023 (Post market)
-0.42 Surprise
  • Reported EPS: $-0.66
  • Estimate: $-0.24
  • Whisper: —
  • Surprise %: -175.0%
Nov 02, 2023
Sep 30, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $-0.57
  • Estimate: $-0.63
  • Whisper: —
  • Surprise %: 9.5%
Aug 03, 2023
Jun 30, 2023 (Post market)
-1.14 Surprise
  • Reported EPS: $-1.94
  • Estimate: $-0.80
  • Whisper: —
  • Surprise %: -142.5%

Financials